Doctor profile · Federal record
Dr. MICHAEL RENDER, PA-C
Physician Assistant · HOFFMAN ESTATES, IL
- NPI 1134679129
- Accepts Medicare
- 10 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
4885 HOFFMAN BLVD STE 407
HOFFMAN ESTATES, IL 601923726
(224) 484-0183
fax (224) 699-9301
Credentials & registration
- NPI registered
- October 2016 — 10 yrs on file
- Profile last updated
- May 10, 2022
- Year of graduation
- 2016 — 10 yrs since
- Specialty taxonomy
- 363A00000X — NUCC code
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1134679129. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
1,227
Distinct HCPCS
10
Medicare allowed
$71,648
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
17003 |
Destruction of precancer skin growth, 2-14 growths | 304 | 75 | $6 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 295 | 211 | $80 | |
17000 |
Destruction of precancer skin growth, 1 growth | 158 | 126 | $43 | |
11102 |
Biopsy of related skin growth, first growth | 141 | 119 | $80 | |
17110 |
Destruction of skin growth, 1-14 growths | 116 | 85 | $100 | |
11103 |
Biopsy of related skin growth, each additional growth | 64 | 42 | $45 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 62 | 62 | $101 | |
99212 |
Established patient office or other outpatient visit, 10-19 minutes | 40 | 39 | $50 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 29 | 23 | $113 | |
11104 |
Punch biopsy, first skin growth | 18 | 17 | $113 |
In context: peer comparison
Among 3 peers in this city , average services per provider: 61. This provider delivers 20× the peer median.Open Payments
Industry payments received
All-time total
$659
Transactions
29
Manufacturers
6
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Dermavant Sciences, Inc. | 10 | $272.65 | |
| ABBVIE INC. | 14 | $188.15 | |
| Verrica Pharmaceuticals Inc. | 1 | $91.69 | |
| Arcutis Biotherapeutics, Inc. | 1 | $58.13 | |
| LEO Pharma Inc. | 2 | $32.10 | |
| E.R. Squibb & Sons, L.L.C. | 1 | $15.93 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
278
Patients
177
Total drug cost
$121,230
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Clobetasol Propionate | Generic | 43 | 34 | $2,368 |
| Fluorouracil | Generic | 30 | 30 | $3,944 |
| Mupirocin | Generic | 29 | 23 | $290 |
| Ciclopirox (Ciclopirox Olamine) | Brand | 28 | 22 | $1,019 |
| Betamethasone Diprop Augmented (Betamethasone/Propylene Glyc) | Brand | 26 | 24 | $1,842 |
| Tacrolimus | Generic | 26 | 21 | $4,736 |
| Doxycycline Hyclate | Generic | 24 | 11 | $1,419 |
| Ketoconazole | Generic | 19 | 0 | $366 |
| Hydroxyzine Hcl | Generic | 15 | 0 | $126 |
| Cosentyx Sensoready (2 Pens) (Secukinumab) | Brand | 14 | 0 | $104,436 |